Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibiton of signaling via the type I insulin-like growth factor receptor. - Dilling,M.B.; Dias,P.; Shapiro,D.N.; German,G.S.; Johnson,R.K.; Houghton,P.J. (Cancer Res, 1994)